Granulocyte colony-stimulating factor(Kura Oncology Inc)

N/A

Report date: 2023/08/24 20:01:02

Base Information

Drug NameGranulocyte colony-stimulating factor(Kura Oncology Inc)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsHematologic NeoplasmsLeukemia, Myeloid, AcuteLeukemia, Myeloid +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesItalySpain

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesKura Oncology Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsHematologic NeoplasmsLeukemia, Myeloid, AcuteLeukemia, Myeloid +[4]

Inactive IndicationsNeoplasms

ATC CodeN/A